This study proved that O-GlcNAcylation is an independent contributor to vascular calcification, leading to a higher risk of MACE, and identified O-GlcNAcylation of AKT as a possible therapeutic target in diabetes mellitus. Here, AKT1 is linked to diabetes mellitus.